CLASS II Device recall · Reported 3 Aug 2022 · FDA Enforcement Report

nordicBrainEX, software versions 2.21 through recalled

NordicNeuroLab AS is recalling nordicBrainEX, software versions 2.21 through 2.3.10, distributed nationwide in the US. The recall was initiated on 16 Jun 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI 07090042059015, software versions 2.21 through 2.3.10
Quantity recalled243 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1462-2022
FDA event ID
90480
Recalling firm
NordicNeuroLab AS, Bergen
Classification
Class II
Status
Terminated
Recall initiated
16 Jun 2022
FDA classified
25 Jul 2022
Reported
3 Aug 2022
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction
Device type
Medical Software

Timeline

16 Jun 2022Recall initiated by company
25 Jul 2022Classified by FDA+39 days
3 Aug 2022Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

When exporting merged results from the BOLD, DSC, and DCE modules of nordicBrainEx, where both the underlay and overlay originated from a multiframe dataset, the resulting output may have left/right sides flipped.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

nordicBrainEX, software versions 2.21 through 2.3.10

Where it was distributed

US Nationwide distribution.

Nationwide

Questions about this recall

Is nordicBrainEX, software versions 2.21 through 2.3.10 recalled?

Yes. NordicNeuroLab AS recalled nordicBrainEX, software versions 2.21 through 2.3.10 on 16 Jun 2022. The recall is Class II and its status is Terminated. Recall number Z-1462-2022.

Why was it recalled?

When exporting merged results from the BOLD, DSC, and DCE modules of nordicBrainEx, where both the underlay and overlay originated from a multiframe dataset, the resulting output may have left/right sides flipped.

Which lots are affected?

UDI 07090042059015, software versions 2.21 through 2.3.10

Where was it sold?

US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from NordicNeuroLab AS

All 8

Other Medical Software recalls

All 903